Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 4
2(50.0%)
N/A
1(25.0%)
Phase 3
1(25.0%)
4Total
Phase 4(2)
N/A(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05137119Phase 4Recruiting

Staphylococcus Aureus Network Adaptive Platform Trial

Role: collaborator

NCT06537609Not ApplicableRecruiting

A Platform Trial for Gram Negative Bloodstream Infections

Role: collaborator

NCT06771050Phase 4Not Yet Recruiting

Randomised Arthroplasty Infection Worldwide Multidomain Adaptive Platform (ROADMAP) Trial

Role: collaborator

NCT04483960Phase 3Active Not Recruiting

Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial

Role: collaborator

All 4 trials loaded